Pasireotide diaspartate
Pasireotide diaspartate用途
Pasireotide, also known as SOM230, is an orphan drug approved for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy. It was developed by Novartis. Pasireotide is a somatostatin analog with a 40-fold increased affinity to somatostatin receptor 5 compared to other somatostatin analogs.
Pasireotide diaspartate名称
[ CAS 号 ]:
820232-50-6
[ 英文名 ]:
Pasireotide diaspartate
[英文别名 ]:
- I4P76SY3N4
- pasireotide aspartate
- Pasireotide diaspartate
- Signifor
Pasireotide diaspartate物理化学性质
[ 分子式 ]:
C66H80N12O17
[ 分子量 ]:
1313.412
[ 精确质量 ]:
1312.576416
推荐生产厂家/供应商:
相关化合物
[Pasireotide diaspartate]化源网提供Pasireotide diaspartateCAS号820232-50-6,Pasireotide diaspartateMSDS及其说明、性质、英文名、生产厂家、作用/用途、分子量、密度、沸点、熔点、结构式等。CAS号查询Pasireotide diaspartate上化源网,专业又轻松。>>电脑版:Pasireotide diaspartate
标题:820232-50-6_Pasireotide diaspartateCAS号:820232-50-6_Pasireotide diaspartate【结构式 性质 英文】 - 化源网 地址:https://www.chemsrc.com/amp/cas/820232-50-6_1567692.html